Abstract:AIM To investigate the effect of various concentrations of tetrandrine on activation of quiescent rat hepatic stellate cells (HSCs) and transforming growth factor-beta (TGF-beta) signaling in vitro. METHODS HSCs were isolated from rats by in situ perfusion of liver and 18% Nycodenz gradient centrifugation, and primarily cultured on uncoated plastic plates for 24 h with DMEM containing 20% fetal bovine serum (FBS/DMEM) before the culture medium was substituted with 2% FBS/DMEM for another 24 h. Then, the HSCs were cultured in 2% FBS/DMEM with tetrandrine (0.25, 0.5, 1, 2 mg/L, respectively). Cell morphological features were observed under an inverted microscope, smooth muscle-alpha-actin (alpha-SMA) was detected by immunocytochemistry and image analysis system, laminin (LN) and type III procollagen (PCIII) in supernatants were determined by radioimmunoassay. TGF-beta1 mRNA, Smad 7 mRNA and Smad 7 protein were analyzed with RT-PCR and Western blotting, respectively. RESULTS Tetrandrine at the concentrations of 0.25-2 mg/L prevented morphological transformation of HSC from the quiescent state to the activated one, while alpha-SMA, LN and PCIII expressions were inhibited. As estimated by gray values, the expression of alpha-SMA in tetrandrine groups (0.25, 0.5, 1, 2 mg/L) was reduced from 21.3% to 42.2% (control: 0.67, tetrandrine groups: 0.82, 0.85, 0.96, or 0.96, respectively, which were statistically different from the control, P<0.01), and the difference was more significant in tetrandrine at 1 and 2 mg/L. The content of LN in supernatants was significantly decreased in tetrandrine groups to 58.5%, 69.1%, 65.8% or 60.0% that of the control respectively, and that of PCIII to 84.6%, 81.5%, 75.7% or 80.7% respectively (P<0.05 vs control), with no significant difference among tetrandrine groups. RT-PCR showed that TGF-beta1 mRNA expression was reduced by tetrandrine treatments from 56.56% to 87.90% in comparison with the control, while Smad 7 mRNA was increased 1.4-4.8 times. The TGF-beta1 mRNA and Smad 7 mRNA expression was in a significant negative correlation (r=-0.755, P<0.01), and both were significantly correlated with alpha-SMA protein expression (r=-0.938, P<0.01; r=0.938, P<0.01, respectively). The up-regulation of Smad 7 protein by tetrandrine (1 mg/L) was confirmed by Western blotting as well. CONCLUSION Tetrandrine has a direct inhibiting effect on the activation of rat HSCs in culture. It up-regulates the expression of Smad 7 which in turn blocks TGF-beta1 expression and signaling.

Progress in Studies of Tetrandrine Against Hepatofibrosis

An Experimental Contrast Study of Tetrandrine on Anti-hepatofibrosis

QSAR Research of Novel Tetrandrine Derivatives Against Human Hepatocellular Carcinoma.

Experimental Studies on the Action of Tetrandrine Against Liver Fibrosis

Optimization of Tetrandrine Treatment in Rat Hepatic Fibrosis Model

Research on the anti-hepatic fibrosis effects and active components of the medicinal plant Tithonia diversifolia

Effect of Tetrandrine on Experimental Hepatic Fibrosis Induced by Bile Duct Ligation and Scission in Rats.

Tetrandrine Prevents Tissue Inhibitor of Metalloproteinase-1 Messenger Rna Expression in Rat Liver Fibrosis

Advanced Progress on the Effect and Mechanism of Tetrandrine

Tetrandrine Inhibits Expressions of C-Fos and C-Jun Mrna in Fibrotic Liver of Rats

Design and Synthesis of Novel Tetrandrine Derivatives As Potential Anti-Tumor Agents Against Human Hepatocellular Carcinoma.

Tetrandrine Protects Mice from Concanavalin A-induced Hepatitis Through Inhibiting NF-κB Activation

Tetrandrine Inhibits Activation of Rat Hepatic Stellate Cells in Vitro Via Transforming Growth Factor-Beta Signaling

Effects of Tetrandrine and Verapamil on Fibroblastic Growth and Proliferation.

Effects of Tetrandrine on Gastric Mucosa and Liver in Portal Hypertensive Rats

Tetrandrine Regulates Hepatic Stellate Cell Activation Via TAK1 and NF-κB Signaling.

Proteomic Analysis of Anti-Tumor Effects by Tetrandrine Treatment in Hepg2 Cells

Tetrandrine inhibits activation of rat hepatic stellate cells stimulated by transforming growth factor-β in vitro via up-regulation of Smad 7

[Therapeutic Effects of Octreotide on Hepatofibrosis-Induced with Carbon Tetrachloride in Rats].

Suppression of expression extracellular matrix in hepatic fibrosis rat with tetrandrine and glycyrrhizinic acid

Local Therapeutic Effect of Tetrandrine and Cisplatin on Hepatocellular Carcinoma in Mice